Parliamentary Panel recommends statutory price capping for unregulated medical devices

A parliamentary committee has proposed a new framework to bring unregulated medical devices under statutory price capping. This step is critical to reduce exorbitant out-of-pocket patient expenses and control wide price variations in essential medical implants. Under the proposed system, high-priority devices will face immediate maximum retail price ceilings or restricted trade margins.